MURICHOLIC ACIDS AND DERIVATIVES FOR CHOLESTASIS TREATMENT
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Mar 6, 2025
app pub date -
Sep 3, 2024
filing date -
Sep 3, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A method of treating a cholestasis liver condition in a subject in need of such therapy, comprising administering to the subject a muricholic acid (MCA), such as α-MCA, β-MCA, ω-MCA, or a glycine- or taurine-conjugated MCA, such as a glycine-conjugated α-MCA, a glycine-conjugated β-MCA, a glycine-conjugated ω-MCA, a taurine-conjugated α-MCA, a taurine-conjugated β-MCA, a taurine-conjugated ω-MCA, or a pharmaceutically-acceptable salt of any of the above.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully